Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02865265
Other study ID # 0109060/16
Secondary ID
Status Completed
Phase N/A
First received August 4, 2016
Last updated August 9, 2016
Start date March 2013
Est. completion date December 2015

Study information

Verified date August 2016
Source San Salvatore Hospital of L'Aquila
Contact n/a
Is FDA regulated No
Health authority Italy: The Italian Medicines Agency
Study type Observational

Clinical Trial Summary

The association between ultrasound-guided Pecs II block and parasternal block can represent a valid alternative in the management of acute and postoperative pain syndrome after quadrantectomy with or without axillary dissection.


Description:

The combination of Pecs II block and PaB provides good management of postoperative pain and can be considered a viable alternative to common anesthetic procedures performed for breast cancer surgery.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date December 2015
Est. primary completion date March 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- 18-75 years of age;

- American Society of Anesthesiologists (ASA) physical status I-III,

- patients scheduled for quadrantectomy with or without axillary dissection

Exclusion Criteria:

- pregnancy;

- body mass index (BMI) >35;

- allergy to local anesthetics;

- skeletal or muscle abnormalities of the chest wall;

- presence of primary or secondary neurological diseases;

- presence of psychiatric diseases;

- history of chronic pain or neuropathic disorders;

- history of drug abuse;

- state of sepsis;

- infection

- tumors of the skin on the chest;

- primary;

- secondary coagulopathies

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
Pecs II and parasternal blocks
Pecs II block was performed at the level of the fourth rib in the fascial plane between the minor pectoral and serratus anterior muscles, and 20 ml of 0.5% levobupivacaine solution were injected. An ultrasound-guided ipsilateral parasternal block was performed via two separate injections of 4 ml of 0.375% levobupivacaine at the level of the 2nd and 4th intercostal space underneath the external intercostal membrane between the major pectoral and intercostal muscles close to the surface of the 2nd and 4th rib.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Emiliano Petrucci

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Pain has been evaluate with visual analogue scale (VAS) at 24 months after surgery Pain was recorded at 24 months after surgery Yes
Secondary Neuropathic postoperative disturbances Neuropathic postoperative disturbances were examined using the von Frey hair test (neuropathic disturbances: present/not present) at 24 months Neuropathic postoperative disturbances were recorded at 24 months after surgery Yes
Secondary Patient satisfaction Patient satisfaction with regard to the anesthetic procedure was assessed using a five-step satisfaction scale (not at all/slightly/somewhat/very/extremely satisfied). Patient satisfaction was evaluated at 1 day after surgery Yes
Secondary Woud healing Wound healing was assessed using a three-step scale (unacceptable/acceptable/excellent healing) in accordance with the surgeon's opinion. Wound healing was assessed at 24 months after surgery Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A